A. A. Ranade

Effect of coadministered beta blocker and COX-2 inhibitor to patients with pancreatic cancer prior to receiving albumin-bound (Nab) paclitaxel.

N. Bascomb, G. Bhattacharyya, K. Babu, 2015 .

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral Talactoferrin in Combination with Carboplatin and Paclitaxel in Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer

S. Nag, J. Madhavan, P. Julka, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Oncology Gold Standard™ consensus statement on counseling patients for molecular testing and personalized cancer care

D. Doval, H. Malhotra, P. Parikh, 2017 .

Clinical and economic implications of the use of nanoparticle paclitaxel (Nanoxel) in India.

G. Bhattacharyya, P. Parikh, R. Kasbekar, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Reversal of Tamoxifen Resistance (Hormone Resistance) by Addition of Sirolimus (mTOR Inhibitor) in Metastatic Breast Cancer

H. Malhotra, M. Singh, P. Parikh, 2011 .

Lung cancer in India: Current status and promising strategies

G. Bhattacharyya, P. Parikh, A. A. Ranade, 2016, South Asian Journal of Cancer.